Brinzolamide is indicated to decrease elevated intraocular pressure in.
This report contains market size and forecasts of Brinzolamide Eye Drop in global, including the following market information:
Global Brinzolamide Eye Drop Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Brinzolamide Eye Drop Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Brinzolamide Eye Drop companies in 2021 (%)
The global Brinzolamide Eye Drop market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
5mg/ml Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Brinzolamide Eye Drop include Novartis Pharmaceuticals UK Ltd, Mylan, Accord Healthcare Limited, Sandoz Limited, Thornton & Ross Ltd and Aspire Pharma Ltd, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Brinzolamide Eye Drop manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Brinzolamide Eye Drop Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Brinzolamide Eye Drop Market Segment Percentages, by Type, 2021 (%)
5mg/ml
10mg/ml
Global Brinzolamide Eye Drop Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Brinzolamide Eye Drop Market Segment Percentages, by Application, 2021 (%)
Hospital
Ophthalmic Clinic
Pharmacy
Others
Global Brinzolamide Eye Drop Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Brinzolamide Eye Drop Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Brinzolamide Eye Drop revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Brinzolamide Eye Drop revenues share in global market, 2021 (%)
Key companies Brinzolamide Eye Drop sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Brinzolamide Eye Drop sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis Pharmaceuticals UK Ltd
Mylan
Accord Healthcare Limited
Sandoz Limited
Thornton & Ross Ltd
Aspire Pharma Ltd